240 related articles for article (PubMed ID: 28138923)
1. "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.
Dean M; Rauscher EA
J Genet Couns; 2017 Dec; 26(6):1301-1313. PubMed ID: 28138923
[TBL] [Abstract][Full Text] [Related]
2. Reproductive decision-making in young female carriers of a BRCA mutation.
Donnelly LS; Watson M; Moynihan C; Bancroft E; Evans DG; Eeles R; Lavery S; Ormondroyd E
Hum Reprod; 2013 Apr; 28(4):1006-12. PubMed ID: 23293217
[TBL] [Abstract][Full Text] [Related]
3. Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
Dean M; Davidson LG
Health Commun; 2018 Feb; 33(2):122-130. PubMed ID: 27976925
[TBL] [Abstract][Full Text] [Related]
4. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
5. Men's and Women's Approaches to Disclosure About BRCA-Related Cancer Risks and Family Planning Decision-Making.
Dean M; Rauscher EA
Qual Health Res; 2018 Dec; 28(14):2155-2168. PubMed ID: 30051759
[TBL] [Abstract][Full Text] [Related]
6. "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.
Dean M
Soc Sci Med; 2016 Aug; 163():21-7. PubMed ID: 27376595
[TBL] [Abstract][Full Text] [Related]
7. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
[TBL] [Abstract][Full Text] [Related]
8. "Take your time, then follow your heart:" Previvors' advice for communicating about family planning after testing positive for a BRCA genetic variant.
Rauscher EA; Dean M
Fam Syst Health; 2017 Dec; 35(4):486-497. PubMed ID: 29283615
[TBL] [Abstract][Full Text] [Related]
9. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
[TBL] [Abstract][Full Text] [Related]
10. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
11. "When information is not enough": A model for understanding BRCA-positive previvors' information needs regarding hereditary breast and ovarian cancer risk.
Dean M; Scherr CL; Clements M; Koruo R; Martinez J; Ross A
Patient Educ Couns; 2017 Sep; 100(9):1738-1743. PubMed ID: 28385363
[TBL] [Abstract][Full Text] [Related]
12. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk management decision making for BRCA+ women.
Leonarczyk TJ; Mawn BE
West J Nurs Res; 2015 Jan; 37(1):66-84. PubMed ID: 24470135
[TBL] [Abstract][Full Text] [Related]
14. Preparing young people for future decision-making about cancer risk in families affected or at risk from hereditary breast cancer: A qualitative interview study.
Rowland E; Plumridge G; Considine AM; Metcalfe A
Eur J Oncol Nurs; 2016 Dec; 25():9-15. PubMed ID: 27865258
[TBL] [Abstract][Full Text] [Related]
15. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
16. Five families living with hereditary breast and ovarian cancer risk.
Norris J; Spelic SS; Snyder C; Tinley S
Clin J Oncol Nurs; 2009 Feb; 13(1):73-80. PubMed ID: 19193551
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal cancer risk management trajectories of BRCA1/2 mutation-positive reproductive-age women.
Young JL; Werner-Lin A; Mueller R; Hoskins L; Epstein N; Greene MH
J Psychosoc Oncol; 2017; 35(4):393-408. PubMed ID: 28332940
[TBL] [Abstract][Full Text] [Related]
18. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N
Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961
[TBL] [Abstract][Full Text] [Related]
19. Communication of BRCA results and family testing in 1,103 high-risk women.
Cheung EL; Olson AD; Yu TM; Han PZ; Beattie MS
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2211-9. PubMed ID: 20699375
[TBL] [Abstract][Full Text] [Related]
20. Integrative Review of Reproductive Decision Making of Women Who Are BRCA Positive.
Skrovanek E; Dunbar-Jacob J; Dunwoody C; Wesmiller S
J Obstet Gynecol Neonatal Nurs; 2020 Nov; 49(6):525-536. PubMed ID: 32926832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
